XML 55 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Note 12 - Segment Reporting
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
Note
12
Segment Reporting
 
The Company operates through
three
segments, CVD, SDC and CVD Materials. The CVD segment is utilized for silicon, silicon germanium, silicon carbide and gallium arsenide processes. SDC is the Company's ultra-high purity manufacturing division in Saugerties, New York. The accounting policies of CVD and SDC are the same as those described in the summary of significant accounting policies (see Note
2
). The Company evaluates performance based on several factors, of which the primary financial measure is earnings before taxes. Included in the CVD Materials segment are our wholly owned subsidiaries, CVD Tantaline Aps and CVD MesoScribe Technologies Corporation.
 
The following table presents certain information regarding the Company's segments as of
December 31, 2020
and
December 31, 2019
and for the years then ended:
 
2020
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
 
CVD
   
 
SDC
   
 
Materials
   
 
Corporate
   
 
Eliminations *
   
 
Consolidated
 
Assets
  $
31,284
    $
6,068
    $
3,593
     
 
    $
(9
)   $
40,936
 
                                                 
Revenue
  $
10,385
    $
4,429
    $
2,556
     
 
    $
(450
)   $
16,920
 
Operating (loss)/income
   
(863
)    
473
     
(4,283
)    
(3,151
)    
 
     
(7,824
)
Pretax (loss)/income
   
(878
)    
481
     
(4,054
)    
(3,151
)    
 
     
(7,602
)
 
2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
 
CVD
   
SDC
   
Materials
   
Corporate
   
Eliminations *
   
Consolidated
 
Assets-revised
  $
34,374
    $
6,003
    $
6,355
     
 
    $
(9
)   $
46,723
 
                                                 
Revenue
  $
14,065
    $
4,498
    $
1,786
     
 
    $
(702
)   $
19,647
 
Operating (loss)/income
   
(1,811
)    
696
     
(537
)    
(3,333
)    
 
     
(4,985
)
Pretax (loss)/income
   
(1,782
)    
719
     
(518
)    
(3,333
)    
 
     
(4,914
)
 
*All elimination entries represent intersegment transactions eliminated in consolidation for external reporting.
2020
Materials segment includes an impairment charge of
$3.6
million related to the Tantaline product line